$NVEC
NVE CORP /NEW/ Stock $nvec

$nvec Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000137647424000214 Filed on May 01, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$6.783M	$7.083M	$29.80M
YoY Change	-23.19%	-44.65%	-22.09%
Cost Of Revenue	$975.5K	$1.738M	$6.773M
YoY Change	-53.09%	-31.29%	-16.0%
Gross Profit	$5.808M	$5.345M	$23.03M
YoY Change	-13.98%	-47.94%	-23.71%
Gross Profit Margin	85.62%	75.46%	77.28%
Selling, General & Admin	$540.4K	$473.6K	$1.781M
YoY Change	-21.4%	-37.08%	-9.26%
% of Gross Profit	9.3%	8.86%	7.73%
Research & Development	$878.5K	$811.3K	$2.731M
YoY Change	26.23%	32.68%	5.71%
% of Gross Profit	15.13%	15.18%	11.86%
Depreciation & Amortization	$75.59K	$152.1K	$308.1K
YoY Change	27.13%	117.79%	19.62%
% of Gross Profit	1.3%	2.85%	1.34%
Operating Expenses	$1.419M	$1.285M	$4.513M
YoY Change	2.56%	-5.81%	-0.75%
Operating Profit	$4.389M	$4.060M	$18.52M
YoY Change	-18.24%	-54.4%	-27.79%
Interest Expense	$494.0K	$508.4K	$1.949M
YoY Change	13.16%	24.58%	34.52%
% of Operating Profit	11.25%	12.52%	10.52%
Other Income/Expense, Net
YoY Change
Pretax Income	$4.883M	$4.569M	$20.47M
YoY Change	-15.88%	-50.94%	-24.45%
Income Tax	$785.2K	$755.7K	$3.343M
% Of Pretax Income	16.08%	16.54%	16.33%
Net Earnings	$4.098M	$3.813M	$17.12M
YoY Change	-6.95%	-53.68%	-24.54%
Net Earnings / Revenue	60.41%	53.83%	57.46%
Basic Earnings Per Share	$0.85		$3.54
Diluted Earnings Per Share	$0.85	$0.79	$3.54
COMMON SHARES
Basic Shares Outstanding	4.834M shares	4.834M shares	4.833M shares
Diluted Shares Outstanding	4.839M shares		4.840M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.68M	$22.20M	$22.20M
YoY Change	59.23%	29.21%	29.21%
Cash & Equivalents	$6.005M	$10.28M	$10.28M
Short-Term Investments	$15.67M	$11.92M	$11.92M
Other Short-Term Assets	$515.4K	$689.4K	$689.4K
YoY Change	-27.12%	3.9%	3.9%
Inventory	$7.165M	$7.159M	$7.159M
Prepaid Expenses	$515.4K	$689.3K
Receivables	$2.100M	$3.145M	$3.145M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$31.46M	$33.19M	$33.19M
YoY Change	20.94%	7.82%	7.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.150M	$1.344M	$1.344M
YoY Change	29.14%	-24.13%	-24.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$31.51M	$30.79M	$30.79M
YoY Change	-20.68%	-14.77%	-14.77%
Other Assets	$1.594M	$1.454M	$1.454M
YoY Change	119.86%	154.13%	154.13%
Total Long-Term Assets	$1.895M	$1.054M	$33.59M
YoY Change	-95.5%	-21.66%	-12.69%
TOTAL ASSETS
Total Short-Term Assets	$31.46M	$33.19M	$33.19M
Total Long-Term Assets	$1.895M	$1.054M	$33.59M
Total Assets	$66.71M	$66.78M	$66.78M
YoY Change	-2.08%	-3.57%	-3.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$174.2K	$127.2K	$127.2K
YoY Change	9.48%	-54.86%	-54.86%
Accrued Expenses	$1.339M	$729.2K	$908.6K
YoY Change	20.36%	-46.98%	-41.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.693M	$1.036M	$1.036M
YoY Change	33.18%	-43.49%	-43.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$132.4K	$175.8K	$175.8K
YoY Change	-56.14%	-48.74%	-48.74%
Total Long-Term Liabilities	$132.4K	$175.8K	$175.8K
YoY Change	-56.14%	-48.74%	-48.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.693M	$1.036M	$1.036M
Total Long-Term Liabilities	$132.4K	$175.8K	$175.8K
Total Liabilities	$1.826M	$1.212M	$1.212M
YoY Change	16.04%	-44.32%	-44.32%
SHAREHOLDERS EQUITY
Retained Earnings	$46.01M	$46.74M
YoY Change	-5.18%	-4.51%
Common Stock	$48.34K	$48.34K
YoY Change	0.01%	0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.88M	$65.57M	$65.57M
YoY Change
Total Liabilities & Shareholders Equity	$66.71M	$66.78M	$66.78M
YoY Change	-2.08%	-3.57%	-3.57%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	$4.098M	$3.813M	$17.12M
YoY Change	-6.95%	-53.68%	-24.54%
Depreciation, Depletion And Amortization	$75.59K	$152.1K	$308.1K
YoY Change	27.13%	117.79%	19.62%
Cash From Operating Activities	$5.852M	$3.132M	$18.25M
YoY Change	16.46%	-27.87%	-4.42%
INVESTING ACTIVITIES
Capital Expenditures	$916.6K	$0.00	$16.73K
YoY Change	22094.53%	-100.0%	-98.21%
Acquisitions
YoY Change
Other Investing Activities	-$4.380M	$7.300M	$9.597M
YoY Change	714.39%	4017.32%	-226.42%
Cash From Investing Activities	-$5.297M	$7.300M	$9.580M
YoY Change	877.32%	4795.39%	-212.35%
FINANCING ACTIVITIES
Cash Dividend Paid	$4.834M		$19.33M
YoY Change	0.06%		0.04%
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$4.834M	-4.834M	-$19.21M
YoY Change	2.55%	-0.37%	-0.67%
NET CHANGE
Cash From Operating Activities	$5.852M	3.132M	$18.25M
Cash From Investing Activities	-$5.297M	7.300M	$9.580M
Cash From Financing Activities	-$4.834M	-4.834M	-$19.21M
Net Change In Cash	-$4.278M	5.599M	$8.614M
YoY Change	1760.27%	-1656.0%	-198.11%
FREE CASH FLOW
Cash From Operating Activities	$5.852M	$3.132M	$18.25M
Capital Expenditures	$916.6K	$0.00	$16.73K
Free Cash Flow	$4.936M	$3.132M	$18.23M
YoY Change	-1.7%	-27.4%	0.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-12196
CY2024	dei	Entity Registrant Name EntityRegistrantName	NVE CORP
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1424202
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	11409 Valley View Road
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Eden Prairie
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55344
CY2024	dei	Entity Address Address Description EntityAddressAddressDescription	Address of principal executive offices
CY2024	dei	Phone Fax Number Description PhoneFaxNumberDescription	Registrant’s telephone number, including area code
CY2024	dei	City Area Code CityAreaCode	952
CY2024	dei	Local Phone Number LocalPhoneNumber	829-9217
CY2024	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2024	dei	Trading Symbol TradingSymbol	NVEC
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Public Float EntityPublicFloat	268000000	usd
CY2024	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4833676	shares
CY2024	dei	Auditor Name AuditorName	Boulay PLLP
CY2024	dei	Auditor Firm AuditorFirmId	542
CY2024	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10283550	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1669896	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	12283630	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	15696135	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	11917779	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	15513095	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3144833	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6523344	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	7158585	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	6417010	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	689349	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	663459	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	33194096	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	30786804	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10501096	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10484365	usd
CY2024Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1956309	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1956309	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11403383	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11095236	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1054022	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1345438	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1453704	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	572038	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	31417890	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	37495846	usd
CY2024Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	30788301	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	36125047	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	289910	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	425843	usd
CY2024Q1	us-gaap	Assets Assets	66780033	usd
CY2023Q1	us-gaap	Assets Assets	69255170	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	127154	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	281712	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	729215	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1375250	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	179372	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175798	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1035741	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1832760	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	175775	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	342908	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1211516	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2175668	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4833676	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4833676	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4830826	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4830826	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	48337	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	48308	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19554812	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19295442	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-777637	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1213858	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	46743005	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	48949610	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	65568517	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	67079502	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66780033	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69255170	usd
CY2024	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	29218063	usd
CY2023	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	37196717	usd
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	586116	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1056875	usd
CY2024	us-gaap	Revenues Revenues	29804179	usd
CY2023	us-gaap	Revenues Revenues	38253592	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	6772533	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	8062311	usd
CY2024	us-gaap	Gross Profit GrossProfit	23031646	usd
CY2023	us-gaap	Gross Profit GrossProfit	30191281	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2731434	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2583994	usd
CY2024	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1771833	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1963105	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9514	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	4512781	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4547099	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	18518865	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	25644182	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	1948720	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1448655	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20467585	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	27092837	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3342886	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4398379	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	17124699	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	22694458	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.54
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.7
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.54
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.7
CY2024	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	4
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	4
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4833146	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4830826	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4839705	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4832096	shares
CY2024	us-gaap	Net Income Loss NetIncomeLoss	17124699	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	22694458	usd
CY2024	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	436221	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-895738	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17560920	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21798720	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	64565129	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-20700	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-895738	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	22694458	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21798720	usd
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	59657	usd
CY2023	us-gaap	Dividends Cash DividendsCash	19323304	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	67079502	usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	117463	usd
CY2024	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	436221	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	17124699	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17560920	usd
CY2024	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	141936	usd
CY2024	us-gaap	Dividends Cash DividendsCash	19331304	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65568517	usd
CY2024	us-gaap	Profit Loss ProfitLoss	17124699	usd
CY2023	us-gaap	Profit Loss ProfitLoss	22694458	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	308147	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	196738	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-106354	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	60868	usd
CY2024	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	9514	usd
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	usd
CY2024	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	141936	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	59657	usd
CY2024	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1003844	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	161894	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3368997	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1818515	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	741575	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1328375	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-110043	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	208532	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-964152	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-726695	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18247411	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19091498	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16731	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	935791	usd
CY2024	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6103185	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	28441317	usd
CY2024	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	15700000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	20750000	usd
CY2024	us-gaap	Proceeds From Contribution In Aid Of Construction ProceedsFromContributionInAidOfConstruction	0	usd
CY2023	us-gaap	Proceeds From Contribution In Aid Of Construction ProceedsFromContributionInAidOfConstruction	100000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9580084	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8527108	usd
CY2024	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	117463	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3	usd
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20697	usd
CY2024	us-gaap	Payments Of Dividends PaymentsOfDividends	19331304	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	19323304	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19213841	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19344004	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	8613654	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8779614	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1669896	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10449510	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10283550	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1669896	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4539071	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4501656	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p style="font:10pt Times New Roman;margin:0"><b>NOTE 1. DESCRIPTION OF BUSINESS</b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:9pt">We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. We operate in one reportable segment.</p>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font:10pt Times New Roman;margin:0"><b>Concentration of Risk and Financial Instruments</b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:9pt">Financial instruments potentially subject to significant concentrations of credit risk consist principally of cash equivalents, marketable securities, and accounts receivable.</p> <p style="font:10pt Times New Roman;margin:0"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:9pt">Cash and cash equivalents have been maintained in financial institutions we believe have high credit quality, however, these accounts may not be federally insured.</p> <p style="font:10pt Times New Roman;margin:0"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:9pt">We have invested our excess cash in corporate-backed and municipal-backed bonds and money market instruments. Our investment policy prescribes purchases of only high-grade securities and limits the amount of credit exposure to any one issuer.</p> <p style="font:10pt Times New Roman;margin:0"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:9pt">Our customers are throughout the world. We generally do not require collateral from our customers, but we perform ongoing credit evaluations of their financial condition. More information on accounts receivable is contained in the paragraph titled “Accounts Receivable and Allowance for Credit Losses” of this note.</p> <p style="font:10pt Times New Roman;margin:0"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:9pt">Additionally, we are dependent on critical suppliers including our packaging vendors and suppliers of certain raw silicon and semiconductor wafers that are incorporated in our products. Industry shortages and supply-chain disruptions in the past several years have increased the risks of supply interruptions.</p>
CY2024	us-gaap	Depreciation Depreciation	308147	usd
CY2023	us-gaap	Depreciation Depreciation	196738	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4833146	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4830826	shares
CY2024	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	6559	usd
CY2023	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	1270	usd
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4839705	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4832096	shares
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:10pt Times New Roman;margin:0"><b>Use of Estimates</b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:9pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	52548876	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	21760575	usd
CY2024Q1	fil	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	22425929	usd
CY2024Q1	fil	Available For Sale Securities Debt Maturities After Three Through Seven Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterThreeThroughSevenYearsFairValue	8362372	usd
CY2024Q1	fil	Marketable Securities Accrued Interest Receivable MarketableSecuritiesAccruedInterestReceivable	460627	usd
CY2023Q1	fil	Marketable Securities Accrued Interest Receivable MarketableSecuritiesAccruedInterestReceivable	425372	usd
CY2024Q1	fil	Fair Values Of Our Marketable Securities FairValuesOfOurMarketableSecurities	52548876	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	52548876	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	52544283	usd
CY2024Q1	fil	Available For Sale Securities Amortized Cost1 AvailableForSaleSecuritiesAmortizedCost1	53544316	usd
CY2024Q1	fil	Available For Sale Securities Gross Unrealized Holding Gains AvailableForSaleSecuritiesGrossUnrealizedHoldingGains	930	usd
CY2024Q1	fil	Available For Sale Securities Gross Unrealized Holding Losses AvailableForSaleSecuritiesGrossUnrealizedHoldingLosses	-996370	usd
CY2024Q1	fil	Available For Sale Securities Estimated Fair Value AvailableForSaleSecuritiesEstimatedFairValue	52548876	usd
CY2023Q1	fil	Available For Sale Securities Amortized Cost1 AvailableForSaleSecuritiesAmortizedCost1	54098122	usd
CY2023Q1	fil	Available For Sale Securities Gross Unrealized Holding Gains AvailableForSaleSecuritiesGrossUnrealizedHoldingGains	1007	usd
CY2023Q1	fil	Available For Sale Securities Gross Unrealized Holding Losses AvailableForSaleSecuritiesGrossUnrealizedHoldingLosses	-1554846	usd
CY2023Q1	fil	Available For Sale Securities Estimated Fair Value AvailableForSaleSecuritiesEstimatedFairValue	52544283	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	3154764	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4902	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	36551534	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	991468	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	39706298	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	996370	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	37084628	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	590967	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	13294817	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	963879	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	50379445	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1554846	usd
CY2024	fil	Unrealized Gain Loss From Marketable Securities UnrealizedGainLossFromMarketableSecurities	558399	usd
CY2023	fil	Unrealized Gain Loss From Marketable Securities UnrealizedGainLossFromMarketableSecurities	-1146618	usd
CY2024	fil	Tax Effects TaxEffects	122178	usd
CY2023	fil	Tax Effects TaxEffects	-250880	usd
CY2024	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	436221	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-895738	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	15000	usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	212440	usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	202926	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9514	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	15000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1982657	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1601962	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2641085	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3781894	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2534843	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1033154	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	7158585	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	6417010	usd
CY2024	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	141936	usd
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	59657	usd
CY2024	us-gaap	Fair Value Measurements Sensitivity Analysis Description FairValueMeasurementsSensitivityAnalysisDescription	Black-Scholes-Merton option-pricing model
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	34500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	66.26
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	29000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	69.52
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6500	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	79.29
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	50.35
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	59.85
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	57.46
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	69.5
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	34500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	66.26
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	33500	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	65.12
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	32000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	63.6
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	22.15
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	9.06
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	36000	shares
CY2024	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y11M15D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	69.5
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	764355	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	33500	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	65.12
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	764355	usd
CY2024	fil	Total Fair Value Of Option Grants1 TotalFairValueOfOptionGrants1	143943	usd
CY2024Q1	fil	Components Of Deferred Tax Assets And Liabilities Unrealized Gain On Marketable Securities ComponentsOfDeferredTaxAssetsAndLiabilitiesUnrealizedGainOnMarketableSecurities	217802	usd
CY2023	fil	Total Fair Value Of Option Grants1 TotalFairValueOfOptionGrants1	58900	usd
CY2024	fil	Unrecognized Stock Based Compensation UnrecognizedStockBasedCompensation	4181	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4145804	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4039848	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	200926	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	195939	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-963470	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	156053	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-40374	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6539	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3342886	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4398379	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4298193	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	5689294	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	180115	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	180091	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	68894	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	255713	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	1125817	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	1265055	usd
CY2024	us-gaap	Income Tax Effects Allocated Directly To Equity Other IncomeTaxEffectsAllocatedDirectlyToEquityOther	59289	usd
CY2023	us-gaap	Income Tax Effects Allocated Directly To Equity Other IncomeTaxEffectsAllocatedDirectlyToEquityOther	49762	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3342886	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4398379	usd
CY2024Q1	fil	Components Of Deferred Tax Assets And Liabilities Paid Time Off Accrual ComponentsOfDeferredTaxAssetsAndLiabilitiesPaidTimeOffAccrual	64190	usd
CY2023Q1	fil	Components Of Deferred Tax Assets And Liabilities Paid Time Off Accrual ComponentsOfDeferredTaxAssetsAndLiabilitiesPaidTimeOffAccrual	52525	usd
CY2024Q1	fil	Components Of Deferred Tax Assets And Liabilities Inventory Reserve ComponentsOfDeferredTaxAssetsAndLiabilitiesInventoryReserve	47042	usd
CY2023Q1	fil	Components Of Deferred Tax Assets And Liabilities Inventory Reserve ComponentsOfDeferredTaxAssetsAndLiabilitiesInventoryReserve	47042	usd
CY2024Q1	fil	Components Of Deferred Tax Assets And Liabilities Depreciation And Amortization ComponentsOfDeferredTaxAssetsAndLiabilitiesDepreciationAndAmortization	-127839	usd
CY2023Q1	fil	Components Of Deferred Tax Assets And Liabilities Depreciation And Amortization ComponentsOfDeferredTaxAssetsAndLiabilitiesDepreciationAndAmortization	-167551	usd
CY2024Q1	fil	Components Of Deferred Tax Assets And Liabilities Stock Based Compensation Deductions ComponentsOfDeferredTaxAssetsAndLiabilitiesStockBasedCompensationDeductions	101668	usd
CY2023Q1	fil	Components Of Deferred Tax Assets And Liabilities Stock Based Compensation Deductions ComponentsOfDeferredTaxAssetsAndLiabilitiesStockBasedCompensationDeductions	71734	usd
CY2009Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2500000	usd
CY2023Q1	fil	Components Of Deferred Tax Assets And Liabilities Unrealized Gain On Marketable Securities ComponentsOfDeferredTaxAssetsAndLiabilitiesUnrealizedGainOnMarketableSecurities	339980	usd
CY2024Q1	fil	Section174 Rd Expense1 Section174RDExpense1	-930946	usd
CY2023Q1	fil	Section174 Rd Expense1 Section174RDExpense1	0	usd
CY2024Q1	fil	Components Of Deferred Tax Assets And Liabilities Unicap263a Inventory ComponentsOfDeferredTaxAssetsAndLiabilitiesUnicap263aInventory	202339	usd
CY2023Q1	fil	Components Of Deferred Tax Assets And Liabilities Unicap263a Inventory ComponentsOfDeferredTaxAssetsAndLiabilitiesUnicap263aInventory	204424	usd
CY2024Q1	fil	Components Of Deferred Tax Assets And Liabilities Other ComponentsOfDeferredTaxAssetsAndLiabilitiesOther	17556	usd
CY2023Q1	fil	Components Of Deferred Tax Assets And Liabilities Other ComponentsOfDeferredTaxAssetsAndLiabilitiesOther	23884	usd
CY2024Q1	fil	Components Of Deferred Tax Assets And Liabilities Deferred Tax Assets ComponentsOfDeferredTaxAssetsAndLiabilitiesDeferredTaxAssets	1453704	usd
CY2023Q1	fil	Components Of Deferred Tax Assets And Liabilities Deferred Tax Assets ComponentsOfDeferredTaxAssetsAndLiabilitiesDeferredTaxAssets	572038	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	151014	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	178640	usd
CY2024Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P2Y
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.035	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	182271	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	184995	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	367266	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Imputed Interest UnrecordedUnconditionalPurchaseObligationImputedInterest	12119	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	355147	usd
CY2024	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	264	shares
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	3520369	usd
CY2024	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	1	pure
CY2024	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03	pure
CY2024	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	101931	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	98029	usd
CY2024Q2	us-gaap	Subsequent Events Date SubsequentEventsDate	2024-05-01
CY2024Q2	us-gaap	Subsequent Event Description SubsequentEventDescription	we announced that our Board had declared a quarterly cash dividend
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1
CY2024Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2024-05-31
CY2024Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2024-05-13

Files In Submission

Name	View Source	Status
0001376474-24-000214-index-headers.html	Edgar Link	pending
0001376474-24-000214-index.html	Edgar Link	pending
0001376474-24-000214.txt	Edgar Link	pending
0001376474-24-000214-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nve10k_1.jpg	Edgar Link	pending
nve10k_2.jpg	Edgar Link	pending
nvec-20240331.htm	Edgar Link	pending
nvec-20240331.xsd	Edgar Link	pending
nve_ex23.htm	Edgar Link	pending
nve_ex31z1.htm	Edgar Link	pending
nve_ex31z2.htm	Edgar Link	pending
nve_ex32.htm	Edgar Link	pending
nve_ex97.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nvec-20240331_def.xml	Edgar Link	unprocessable
nvec-20240331_lab.xml	Edgar Link	unprocessable
nvec-20240331_pre.xml	Edgar Link	unprocessable
nvec-20240331_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nvec-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVEC
NVE CORP /NEW/ Stock $nvec

2024 Q2 Form 10-K Financial Statement

#000137647424000214 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVEC NVE CORP /NEW/ Stock $nvec

2024 Q2 Form 10-K Financial Statement

#000137647424000214 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVEC
NVE CORP /NEW/ Stock $nvec